VIATRIS INC. for VIATRIS INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to epinephrine auto-injectors pricing Prescription drug pricing issues, Generic Drugs Drug Supply Chain Security Act implementation of pharmaceutical distribution REMS program, S. 3056 CREATES Act, H.R. 2841 FAST Generics Act Biologics Price Competition and Innovation Act (BPCIA) Generic and Biosimilar user fee program re-authorization
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE MCCLINTIC-COATES | — |
| NIMISH SHAH | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| MYLAN NV | United Kingdom | United Kingdom | 100.0% | — |
| MYLAN HOLDINGS LIMITED | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.